Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...
HANOI, VIETNAM, January 7, 2026 / EINPresswire.com / — Vinmec Healthcare System is expanding its medical services portfolio to better serve international patients through medical tourism, positioning ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...
So far, the BCMA-targeted CAR has shown early success in four Australian multiple myeloma patients in a Phase I trial.
CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...
Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...
Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...
The initiative integrates medical and beauty care with tourism services into a seamless, family-focused experience for overseas visitors to Japan. KAMAKURA CITY, KANAGAWA, JAPAN, January 5, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results